41 related articles for article (PubMed ID: 32372307)
1. BCAR4 facilitates trastuzumab resistance and EMT in breast cancer via sponging miR-665 and interacting with YAP1.
Ye X; Liu Q; Qin X; Ma Y; Sheng Q; Wu X; Chen S; Huang L; Sun Y
FASEB J; 2024 Apr; 38(7):e23589. PubMed ID: 38572594
[TBL] [Abstract][Full Text] [Related]
2. miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells.
Yue D; Qin X
Cancer Gene Ther; 2019 Feb; 26(1-2):1-10. PubMed ID: 29925897
[TBL] [Abstract][Full Text] [Related]
3. Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance.
Xin F; Li M; Balch C; Thomson M; Fan M; Liu Y; Hammond SM; Kim S; Nephew KP
Bioinformatics; 2009 Feb; 25(4):430-4. PubMed ID: 19091772
[TBL] [Abstract][Full Text] [Related]
4. A combined approach with gene-wise normalization improves the analysis of RNA-seq data in human breast cancer subtypes.
Li X; Rouchka EC; Brock GN; Yan J; O'Toole TE; Tieri DA; Cooper NGF
PLoS One; 2018; 13(8):e0201813. PubMed ID: 30089167
[TBL] [Abstract][Full Text] [Related]
5. The prognostic genes model of breast cancer drug resistance based on single-cell sequencing analysis and transcriptome analysis.
Liu Y; Dong L; Ma J; Chen L; Fang L; Wang Z
Clin Exp Med; 2024 May; 24(1):113. PubMed ID: 38795164
[TBL] [Abstract][Full Text] [Related]
6. Emerging role of microRNAs in drug-resistant breast cancer.
Majumder S; Jacob ST
Gene Expr; 2011; 15(3):141-51. PubMed ID: 22268296
[TBL] [Abstract][Full Text] [Related]
7. Combined transcriptome and proteome analysis reveals MSN and ARFIP2 as biomarkers for trastuzumab resistance of breast cancer.
Shi X; Sheng Y; Fei H; Wei B; Zhang Z; Xia X; Mao C; Si X
Breast Cancer Res Treat; 2024 May; ():. PubMed ID: 38750271
[TBL] [Abstract][Full Text] [Related]
8. A regulation probability model-based meta-analysis of multiple transcriptomics data sets for cancer biomarker identification.
Xie XP; Xie YF; Wang HQ
BMC Bioinformatics; 2017 Aug; 18(1):375. PubMed ID: 28830341
[TBL] [Abstract][Full Text] [Related]
9. Retraction Note: miR-182 regulates trastuzumab resistance by targeting MET in breast cancer cells.
Yue D; Qin X
Cancer Gene Ther; 2024 Jun; ():. PubMed ID: 38839893
[No Abstract] [Full Text] [Related]
10. Chemically Induced Hypoxia Enhances miRNA Functions in Breast Cancer.
Gervin E; Shin B; Opperman R; Cullen M; Feser R; Maiti S; Majumder M
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32707933
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of Seaweed Compounds, Alone or Combined to Reference Drugs, against Breast Cell Lines Cultured in 2D and 3D.
Malhão F; Ramos AA; Macedo AC; Rocha E
Toxics; 2021 Jan; 9(2):. PubMed ID: 33572635
[TBL] [Abstract][Full Text] [Related]
12. Targeting HER2 heterogeneity in early-stage breast cancer.
Pernas S; Tolaney SM
Curr Opin Oncol; 2020 Nov; 32(6):545-554. PubMed ID: 32925204
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MCM3AP-AS1 promotes chemoresistance in triple-negative breast cancer through the miR-524-5p/RBM39 axis.
Wang Y; Wang X; Sun H; Zhang Z; Gu J
Mol Cell Biochem; 2024 Mar; ():. PubMed ID: 38472681
[TBL] [Abstract][Full Text] [Related]
14. JAK1 Is a Novel Target of Tumor- and Invasion-Suppressive microRNA 494-5p in Colorectal Cancer.
Patil N; Abdelrahim OG; Leupold JH; Allgayer H
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201452
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome-Based Traits of Radioresistant Sublines of Non-Small Cell Lung Cancer Cells.
Pustovalova M; Malakhov P; Guryanova A; Sorokin M; Suntsova M; Buzdin A; Osipov AN; Leonov S
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769365
[TBL] [Abstract][Full Text] [Related]
16. The RNA-Binding Motif Protein Family in Cancer: Friend or Foe?
Li Z; Guo Q; Zhang J; Fu Z; Wang Y; Wang T; Tang J
Front Oncol; 2021; 11():757135. PubMed ID: 34804951
[TBL] [Abstract][Full Text] [Related]
17. Integrative bioinformatics analysis reveals miR-494 and its target genes as predictive biomarkers of trastuzumab-resistant breast cancer.
Hermawan A; Putri H
J Egypt Natl Canc Inst; 2020 Apr; 32(1):16. PubMed ID: 32372307
[TBL] [Abstract][Full Text] [Related]
18. Exosomal miR-1246 and miR-155 as predictive and prognostic biomarkers for trastuzumab-based therapy resistance in HER2-positive breast cancer.
Zhang Z; Zhang L; Yu G; Sun Z; Wang T; Tian X; Duan X; Zhang C
Cancer Chemother Pharmacol; 2020 Dec; 86(6):761-772. PubMed ID: 33068176
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy.
Zhu QN; Renaud H; Guo Y
Hereditas; 2018; 155():17. PubMed ID: 29371858
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
